Breast Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Breast Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 2 (2005), Issue 1 (January)

1. Isolation of a stromal cell line from an early passage of a mouse mammary tumor line: a model for stromal parenchymal interactions.
   J Cell Physiol, 202(3): 672-82. [Abstract] [Full-text]
2. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors.
   J Clin Invest, 115(1): 44-55. [Abstract] [Full-text]
3. Breast cancer: integrating the patient with her genome.
   Trends Biotechnol, 23(1): 3-5. [Abstract] [Full-text]
4. Acute complications of MammoSite brachytherapy: a single institution's initial clinical experience.
   Int J Radiat Oncol Biol Phys, 61(1): 169-74. [Abstract] [Full-text]
5. Analysis of axillary coverage during tangential radiation therapy to the breast.
   Int J Radiat Oncol Biol Phys, 61(1): 163-8. [Abstract] [Full-text]
6. Long-term results of adjuvant hypofractionated radiotherapy for breast cancer in elderly patients.
   Int J Radiat Oncol Biol Phys, 61(1): 154-62. [Abstract] [Full-text]
7. Late recurrence of dermatofibrosarcoma protuberans in the female breast: a case report.
   Br J Plast Surg, 58(1): 84-7. [Abstract] [Full-text]
8. Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis.
   Mod Pathol, 18(1): 26-35. [Abstract] [Full-text]
9. Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression.
   Mod Pathol, 18(1): 143-52. [Abstract] [Full-text]
10. Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis.
    J Natl Cancer Inst, 97(1): 51-9. [Abstract] [Full-text]
11. CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.
    J Natl Cancer Inst, 97(1): 30-9. [Abstract] [Full-text]
12. Cellular retinol-binding protein I, a regulator of breast epithelial retinoic acid receptor activity, cell differentiation, and tumorigenicity.
    J Natl Cancer Inst, 97(1): 21-9. [Abstract] [Full-text]
13. Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody.
    J Natl Cancer Inst, 97(1): 14-21. [Abstract] [Full-text]
14. Plasma carotenoids, retinol, and tocopherols and risk of breast cancer.
    Am J Epidemiol, 161(2): 153-60. [Abstract] [Full-text]
15. Pesticide use and breast cancer risk among farmers' wives in the agricultural health study.
    Am J Epidemiol, 161(2): 121-35. [Abstract] [Full-text]
16. Breast cancer in African-American women.
    Oncologist, 10(1): 1-14. [Abstract] [Full-text]
17. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?
    J Am Coll Surg, 200(1): 10-4. [Abstract] [Full-text]
18. DNA damage in peripheral lymphocytes of untreated breast cancer patients.
    Arch Med Res, 35(6): 480-3. [Abstract] [Full-text]
19. Matching health messages to monitor-blunter coping styles to motivate screening mammography.
    Health Psychol, 24(1): 58-67. [Abstract] [Full-text]
20. Deregulation of cell proliferation by polycyclic aromatic hydrocarbons in human breast carcinoma MCF-7 cells reflects both genotoxic and nongenotoxic events.
    Toxicol Sci, 83(2): 246-56. [Abstract] [Full-text]
21. Co-culture of primary human mammary fibroblasts and MCF-7 cells as an in vitro breast cancer model.
    Toxicol Sci, 83(2): 257-63. [Abstract] [Full-text]
22. Building a health promotion agenda in local newspapers.
    Health Educ Res, 20(1): 51-60. [Abstract] [Full-text]
23. Towards discovery-driven translational research in breast cancer.
    FEBS J, 272(1): 2-15. [Abstract] [Full-text]
24. Prevention of hormone-related cancers: breast cancer.
    J Clin Oncol, 23(2): 357-67. [Abstract] [Full-text]
25. Functional identification of a BAC clone from 16q24 carrying a senescence gene SEN16 for breast cancer cells.
    Oncogene, 24(1): 47-54. [Abstract] [Full-text]
26. A case of bronchiolitis obliterans organizing pneumonia syndrome with preceding radiation pneumonitis after breast-conserving therapy.
    Jpn J Clin Oncol, 34(12): 755-8. [Abstract] [Full-text]
27. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.
    Lancet, 365(9453): 60-2. [Abstract] [Full-text]
28. Biopathologic profile of breast cancer core biopsy: is it always a valid method?
    Cancer Lett, 218(1): 117-21. [Abstract] [Full-text]
29. Cytotoxic and proapoptotic activity of ent-16beta-17alpha-dihydroxykaurane on human mammary carcinoma cell line MCF-7.
    Cancer Lett, 218(1): 109-16. [Abstract] [Full-text]
30. Four peptide hormones decrease the number of human breast adenocarcinoma cells.
    Eur J Clin Invest, 35(1): 60-9. [Abstract] [Full-text]
31. Mass mapping of cancer cell lysates using two-dimensional liquid separations, electrospray-time of flight-mass spectrometry, and automated data processing.
    Electrophoresis, 26(1): 248-56. [Abstract] [Full-text]
32. Enamel matrix derivative is a potent inhibitor of breast cancer cell attachment to bone.
    Life Sci, 76(11): 1211-21. [Abstract] [Full-text]
33. Reduction mammaplasty specimens and occult breast carcinomas.
    Eur J Surg Oncol, 31(1): 19-21. [Abstract] [Full-text]
34. The prevalence of non-sentinel node metastases in breast cancer patients with sentinel node micrometastases.
    Eur J Surg Oncol, 31(1): 13-8. [Abstract] [Full-text]
35. Tubular carcinoma of the breast: outcome and loco-regional recurrence in 307 patients.
    Eur J Surg Oncol, 31(1): 9-12. [Abstract] [Full-text]
36. Mammary ductoscopy: current status and future prospects.
    Eur J Surg Oncol, 31(1): 3-8. [Abstract] [Full-text]
37. Correlation of tissue lipid peroxidation and antioxidants with clinical stage and menopausal status in patients with adenocarcinoma of the breast.
    Clin Biochem, 38(2): 154-8. [Abstract] [Full-text]
38. Neoadjuvant chemotherapy in breast cancer.
    Br J Surg, 92(1): 14-23. [Abstract] [Full-text]
39. Role of Rho/ROCK and p38 MAP kinase pathways in transforming growth factor-beta-mediated Smad-dependent growth inhibition of human breast carcinoma cells in vivo.
    J Biol Chem, 280(2): 1024-36. [Abstract] [Full-text]
40. Consumption of vegetables and fruits and risk of breast cancer.
    JAMA, 293(2): 183-93. [Abstract] [Full-text]
41. Bilateral primary lymphoma of the breast: a case report initially diagnosed by FNAC.
    Diagn Cytopathol, 32(2): 114-8. [Abstract] [Full-text]
42. Construction of robust prognostic predictors by using projective adaptive resonance theory as a gene filtering method.
    Bioinformatics, 21(2): 179-86. [Abstract] [Full-text]
43. Outcome signature genes in breast cancer: is there a unique set?
    Bioinformatics, 21(2): 171-8. [Abstract] [Full-text]
44. Allergic reactions to isosulfan blue in sentinel lymph node mapping.
    Breast J, 11(1): 70-2. [Abstract] [Full-text]
45. Predictors of quality of life in women with a bilateral prophylactic mastectomy.
    Breast J, 11(1): 65-9. [Abstract] [Full-text]
46. Knowledge, perceptions, and attitudes of Hong Kong Chinese women on screening mammography and early breast cancer management.
    Breast J, 11(1): 52-6. [Abstract] [Full-text]
47. Standardized on-slide control for quality assurance in the immunohistochemical assessment of therapeutic target molecules in breast cancer.
    Breast J, 11(1): 34-40. [Abstract] [Full-text]
48. Internal mammary sentinel lymph node mapping for invasive breast cancer: implications for staging and treatment.
    Breast J, 11(1): 29-33. [Abstract] [Full-text]
49. Radial scars of the breast: contrast-enhanced magnetic resonance mammography appearance.
    Breast J, 11(1): 23-8. [Abstract] [Full-text]
50. Mucocele-like lesions of the breast: a benign cause for indeterminate or suspicious mammographic microcalcifications.
    Breast J, 11(1): 15-22. [Abstract] [Full-text]
51. Histologic grading at breast core needle biopsy: comparison with results from the excised breast specimen.
    Breast J, 11(1): 9-14. [Abstract] [Full-text]
52. High nuclear grade, frequent mitotic activity, cyclin D1 and p53 overexpression are associated with stromal invasion in mammary intracystic papillary carcinoma.
    Breast J, 11(1): 2-8. [Abstract] [Full-text]
53. Random-effects Cox proportional hazards model: general variance components methods for time-to-event data.
    Genet Epidemiol, 28(2): 97-109. [Abstract] [Full-text]
54. Breast cancer incidence in the city and province of Palermo in 1999-2002: a Breast Cancer Registry report.
    Ann N Y Acad Sci, 1028: 473-80. [Abstract] [Full-text]
55. Expression levels and clinical-pathological correlations of HER2/neu in primary and metastatic human breast cancer.
    Ann N Y Acad Sci, 1028: 463-72. [Abstract] [Full-text]
56. The role of endogenous hormones in the etiology and prevention of breast cancer: the epidemiological evidence.
    Ann N Y Acad Sci, 1028: 273-82. [Abstract] [Full-text]
57. Sex steroids, carcinogenesis, and cancer progression.
    Ann N Y Acad Sci, 1028: 233-46. [Abstract] [Full-text]
58. Impact of menstrual and reproductive factors on breast cancer risk in Japan: results of the JACC study.
    Cancer Sci, 96(1): 57-62. [Abstract] [Full-text]
59. Correlation of KIT and EGFR overexpression with invasive ductal breast carcinoma of the solid-tubular subtype, nuclear grade 3, and mesenchymal or myoepithelial differentiation.
    Cancer Sci, 96(1): 48-53. [Abstract] [Full-text]
60. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells.
    Endocrinology, 146(2): 624-32. [Abstract] [Full-text]
61. Transcriptional and posttranscriptional regulation of fibulin-1 by estrogens leads to differential induction of messenger ribonucleic acid variants in ovarian and breast cancer cells.
    Endocrinology, 146(2): 760-8. [Abstract] [Full-text]
62. Perceptions about breast cancer among African American women: do selected educational materials challenge them?
    Patient Educ Couns, 56(2): 197-204. [Abstract] [Full-text]
63. Development and validation of a Breast Cancer Genetic Counseling Knowledge Questionnaire.
    Patient Educ Couns, 56(2): 182-91. [Abstract] [Full-text]
64. The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy.
    J Surg Res, 123(1): 158-69. [Abstract] [Full-text]
65. Proteomics of breast carcinoma.
    J Chromatogr B Analyt Technol Biomed Life Sci, 815(1): 215-25. [Abstract] [Full-text]
66. Body mass index and breast cancer risk in African American women.
    Ann Epidemiol, 15(2): 123-8. [Abstract] [Full-text]
67. Residential mobility in the California Teachers Study: implications for geographic differences in disease rates.
    Soc Sci Med, 60(7): 1547-55. [Abstract] [Full-text]
68. Importance of the central region of lamprey gonadotropin-releasing hormone III in the inhibition of breast cancer cell growth.
    Peptides, 26(3): 419-22. [Abstract] [Full-text]
69. Molecular evolution of breast cancer.
    J Pathol, 205(2): 248-54. [Abstract] [Full-text]
70. Improving the reproducibility of diagnosing micrometastases and isolated tumor cells.
    Cancer, 103(2): 358-67. [Abstract] [Full-text]
71. Sexual dysfunction in breast cancer survivors.
    Onkologie, 28(1): 29-34. [Abstract] [Full-text]
72. HOXA5-twist interaction alters p53 homeostasis in breast cancer cells.
    J Biol Chem, 280(3): 2294-9. [Abstract] [Full-text]
73. A novel multiplex RT-PCR system detects human endogenous retrovirus-K in breast cancer.
    Arch Virol, 150(1): 177-84. [Abstract] [Full-text]
74. Metastatic breast adenocarcinoma masquerading as colonic primary. Report of two cases.
    Tech Coloproctol, 8: s135-7. [Abstract] [Full-text]
75. Metachronous breast carcinoma (second malignancy), following "cure" from colorectal carcinoma.
    Tech Coloproctol, 8: s129-31. [Abstract] [Full-text]
76. Volume of screening mammography and performance in the Quebec population-based Breast Cancer Screening Program.
    CMAJ, 172(2): 195-9. [Abstract] [Full-text]
77. Risk factors for estrogen receptor-positive breast cancer.
    Arch Surg, 140(1): 58-62. [Abstract] [Full-text]
78. Role of human cripto-1 in tumor angiogenesis.
    J Natl Cancer Inst, 97(2): 132-41. [Abstract] [Full-text]
79. DNA repair capacity of lymphoblastoid cell lines from sisters discordant for breast cancer.
    J Natl Cancer Inst, 97(2): 127-32. [Abstract] [Full-text]
80. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
    J Natl Cancer Inst, 97(2): 116-26. [Abstract] [Full-text]
81. Cystic hypersecretory carcinoma: rare and poorly recognized variant of intraductal carcinoma of the breast. Report of five cases.
    Histopathology, 46(1): 43-9. [Abstract] [Full-text]
82. PPARgamma expression in breast cancer: clinical value and correlation with ERbeta.
    Histopathology, 46(1): 37-42. [Abstract] [Full-text]
83. Hypoxia-inducible factor-1alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer.
    Histopathology, 46(1): 31-6. [Abstract] [Full-text]
84. Expression of cell adhesion molecules, CD44s and E-cadherin, and microvessel density in invasive micropapillary carcinoma of the breast.
    Histopathology, 46(1): 24-30. [Abstract] [Full-text]
85. Malignant wounds in women with breast cancer: feminine and sexual perspectives.
    J Clin Nurs, 14(1): 56-64. [Abstract] [Full-text]
86. Noninvasive molecular imaging of MYC mRNA expression in human breast cancer xenografts with a [99mTc]peptide-peptide nucleic acid-peptide chimera.
    Bioconjug Chem, 16(1): 70-9. [Abstract] [Full-text]
87. Immunophenotype of lymphocytic infiltration in medullary carcinoma of the breast.
    Virchows Arch, 446(1): 10-4. [Abstract] [Full-text]
88. Partial breast irradiation after breast-conserving surgery.
    Strahlenther Onkol, 181(1): 1-8. [Abstract] [Full-text]
89. Docosahexaenoic acid from a cultured microalga inhibits cell growth and induces apoptosis by upregulating Bax/Bcl-2 ratio in human breast carcinoma MCF-7 cells.
    Ann N Y Acad Sci, 1030: 361-8. [Abstract] [Full-text]
90. Analysis of the effects of different alcohols on MCF-7 human breast cancer cells.
    Ann N Y Acad Sci, 1030: 78-85. [Abstract] [Full-text]
91. Up-front tandem high-dose chemotherapy compared with standard chemotherapy with doxorubicin and paclitaxel in metastatic breast cancer: results of a randomized trial.
    J Clin Oncol, 23(3): 432-40. [Abstract] [Full-text]
92. Prediction of docetaxel response in human breast cancer by gene expression profiling.
    J Clin Oncol, 23(3): 422-31. [Abstract] [Full-text]
93. Model describing the relationship between pharmacokinetics and hematologic toxicity of the epirubicin-docetaxel regimen in breast cancer patients.
    J Clin Oncol, 23(3): 413-21. [Abstract] [Full-text]
94. Alternative phospholipase D/mTOR survival signal in human breast cancer cells.
    Oncogene, 24(4): 672-9. [Abstract] [Full-text]
95. 17beta-Estradiol upregulates and activates WOX1/WWOXv1 and WOX2/WWOXv2 in vitro: potential role in cancerous progression of breast and prostate to a premetastatic state in vivo.
    Oncogene, 24(4): 714-23. [Abstract] [Full-text]
96. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.
    J Clin Oncol, 23(3): 619-29. [Abstract] [Full-text]
97. Incidence of febrile neutropenia and neutropenic infections in elderly patients receiving anthracycline-based chemotherapy for breast cancer without primary prophylaxis with colony-stimulating factors.
    Crit Rev Oncol Hematol, 53(2): 125-31. [Abstract] [Full-text]
98. The role of early expression of inducible nitric oxide synthase in human breast cancer.
    Eur J Cancer, 41(2): 265-71. [Abstract] [Full-text]
99. Two years of adjuvant tamoxifen in premenopausal patients with breast cancer: a randomised, controlled trial with long-term follow-up.
    Eur J Cancer, 41(2): 256-64. [Abstract] [Full-text]
100. Combination regimen of epirubicin, vinorelbine and 5-fluorouracil continuous infusion as first-line chemotherapy in anthracycline-naive metastatic breast cancer patients.
     Eur J Cancer, 41(2): 249-55. [Abstract] [Full-text]
101. Minimal risk of macrometastases in the non-sentinel axillary lymph nodes in breast cancer patients with micrometastatic sentinel lymph nodes and preoperatively ultrasonically uninvolved axillary lymph nodes.
     Eur J Cancer, 41(2): 244-8. [Abstract] [Full-text]
102. Role of routine preoperative lymphoscintigraphy in sentinel node biopsy for breast cancer.
     Eur J Cancer, 41(2): 238-43. [Abstract] [Full-text]
103. Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection.
     Eur J Cancer, 41(2): 231-7. [Abstract] [Full-text]
104. Metastases of breast carcinoma to the uterus. Report of two cases, one harboring a primary endometrioid carcinoma, with review of the literature.
     Gynecol Oncol, 96(2): 543-7. [Abstract] [Full-text]
105. Soyasaponin-I-modified invasive behavior of cancer by changing cell surface sialic acids.
     Gynecol Oncol, 96(2): 415-22. [Abstract] [Full-text]
106. Breast cancer incidence: what do the figures mean?
     J Eval Clin Pract, 11(1): 27-31. [Abstract] [Full-text]
107. Aromatase inhibitors: rationale and use in breast cancer.
     Annu Rev Med, 56: 103-16. [Abstract] [Full-text]
108. Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases.
     J Cancer Res Clin Oncol, 131(3): 191-8. [Abstract] [Full-text]
109. The 3020insC allele of NOD2 predisposes to early-onset breast cancer.
     Breast Cancer Res Treat, 89(1): 91-3. [Abstract] [Full-text]
110. Locally advanced breast cancer in octogenarian women.
     Breast Cancer Res Treat, 89(1): 81-90. [Abstract] [Full-text]
111. The impact of having relatives affected with breast cancer on psychological distress in women at increased risk for hereditary breast cancer.
     Breast Cancer Res Treat, 89(1): 75-80. [Abstract] [Full-text]
112. The sentinel lymph node biopsy under local anesthesia in breast carcinoma: experience of the European Institute of Oncology and impact on quality of life.
     Breast Cancer Res Treat, 89(1): 69-74. [Abstract] [Full-text]
113. Reduced rates of cancer-related worries and mortality associated with guideline surveillance after breast cancer therapy.
     Breast Cancer Res Treat, 89(1): 61-7. [Abstract] [Full-text]
114. Florence-Sydney Breast Biopsy Study: sensitivity of ultrasound-guided versus freehand fine needle biopsy of palpable breast cancer.
     Breast Cancer Res Treat, 89(1): 55-9. [Abstract] [Full-text]
115. The effect of age, race, tumor size, tumor grade, and disease stage on invasive ductal breast cancer survival in the U.S. SEER database.
     Breast Cancer Res Treat, 89(1): 47-54. [Abstract] [Full-text]
116. Prognostic factors affecting the natural history of node-negative breast cancer.
     Breast Cancer Res Treat, 89(1): 35-45. [Abstract] [Full-text]
117. High preoperative serum TIMP-1 is a prognostic indicator for survival in breast carcinoma.
     Breast Cancer Res Treat, 89(1): 29-34. [Abstract] [Full-text]
118. Relationship of depression to patient satisfaction: findings from the barriers to breast cancer study.
     Breast Cancer Res Treat, 89(1): 23-8. [Abstract] [Full-text]
119. Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer.
     Breast Cancer Res Treat, 89(1): 15-21. [Abstract] [Full-text]
120. SHP-2 promoting migration and metastasis of MCF-7 with loss of E-cadherin, dephosphorylation of FAK and secretion of MMP-9 induced by IL-1beta in vivo and in vitro.
     Breast Cancer Res Treat, 89(1): 5-14. [Abstract] [Full-text]
121. Biweekly administration of gemcitabine and vinorelbine as first line therapy in elderly advanced breast cancer.
     Breast Cancer Res Treat, 89(1): 1-3. [Abstract] [Full-text]
122. Can hyperbaric oxygen therapy reduce breast cancer treatment-related lymphedema? A pilot study.
     J Womens Health (Larchmt), 13(9): 1008-18. [Abstract] [Full-text]
123. Prospective evaluation of factors influencing success rates of sentinel node biopsy in 814 breast cancer patients.
     Cancer Biother Radiopharm, 19(6): 784-90. [Abstract] [Full-text]
124. Biodistribution and dosimetry of (99m)Tc-depreotide (P829) in patients suffering from breast carcinoma.
     Cancer Biother Radiopharm, 19(6): 776-83. [Abstract] [Full-text]
125. The efficacy of tamoxifen in estrogen receptor-positive breast cancer cells is enhanced by a medical nutriment.
     Cancer Biother Radiopharm, 19(6): 746-53. [Abstract] [Full-text]
126. Safety, pharmacokinetics, immunogenicity, and biodistribution of (186)Re-labeled humanized monoclonal antibody BIWA 4 (Bivatuzumab) in patients with early-stage breast cancer.
     Cancer Biother Radiopharm, 19(6): 720-9. [Abstract] [Full-text]
127. The evolution of accelerated, partial breast irradiation as a potential treatment option for women with newly diagnosed breast cancer considering breast conservation.
     Cancer Biother Radiopharm, 19(6): 673-705. [Abstract] [Full-text]
128. Diagnostic value of bone remodeling markers in the diagnosis of bone metastases in patients with breast cancer.
     J Pharm Biomed Anal, 37(1): 171-6. [Abstract] [Full-text]
129. Regulation of the human vitamin D3 receptor promoter in breast cancer cells is mediated through Sp1 sites.
     Mol Cell Endocrinol, 230(1): 59-68. [Abstract] [Full-text]
130. Sex hormone-binding globulin antagonizes the anti-apoptotic effect of estradiol in breast cancer cells.
     Mol Cell Endocrinol, 230(1): 31-7. [Abstract] [Full-text]
131. Estrogen receptor independent rapid non-genomic effects of environmental estrogens on [Ca2+]i in human breast cancer cells.
     Mol Cell Endocrinol, 230(1): 23-30. [Abstract] [Full-text]
132. Computer-assisted quantitative assessment of power Doppler US: effects of microbubble contrast agent in the differentiation of breast tumors.
     Eur J Radiol, 53(2): 238-44. [Abstract] [Full-text]
133. Visualisation of calcifications and thin collagen strands in human breast tumour specimens by the diffraction-enhanced imaging technique: a comparison with conventional mammography and histology.
     Eur J Radiol, 53(2): 226-37. [Abstract] [Full-text]
134. Initial evaluation of breast cancer using Tc-99m sestamibi scintimammography.
     Eur J Radiol, 53(2): 206-12. [Abstract] [Full-text]
135. Dynamic magnetic resonance imaging in determining histopathological prognostic factors of invasive breast cancers.
     Eur J Radiol, 53(2): 199-205. [Abstract] [Full-text]
136. Comparison of quantitative and visual analysis of Tc-99m MIBI scintimammography for detection of primary breast cancer.
     Eur J Radiol, 53(2): 192-8. [Abstract] [Full-text]
137. The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double-blind, placebo-controlled trial.
     BJOG, 112(2): 228-33. [Abstract] [Full-text]
138. Polymorphisms in angiotensin II type 1 receptor and angiotensin I-converting enzyme genes and breast cancer risk among Chinese women in Singapore.
     Carcinogenesis, 26(2): 459-64. [Abstract] [Full-text]
139. A population-based assessment of the clustering of breast cancer in families eligible for testing of BRCA1 and BRCA2 mutations.
     Ann Oncol, 16(2): 322-9. [Abstract] [Full-text]
140. Good clinical response of breast cancers to neoadjuvant chemoendocrine therapy is associated with improved overall survival.
     Ann Oncol, 16(2): 267-72. [Abstract] [Full-text]
141. Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications.
     Ann Oncol, 16(2): 263-6. [Abstract] [Full-text]
142. Development of axillary surgery in breast cancer.
     Ann Oncol, 16(2): 259-62. [Abstract] [Full-text]
143. Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer).
     Ann Oncol, 16(2): 253-8. [Abstract] [Full-text]
144. Evaluation of anemia, neutropenia and skin toxicities in standard or dose-dense doxorubicin/cyclophosphamide (AC)-paclitaxel or docetaxel adjuvant chemotherapy in breast cancer.
     Ann Oncol, 16(2): 247-52. [Abstract] [Full-text]
145. Detection of CK-19 mRNA-positive cells in the peripheral blood of breast cancer patients with histologically and immunohistochemically negative axillary lymph nodes.
     Ann Oncol, 16(2): 240-6. [Abstract] [Full-text]
146. Serum HER2 extracellular domain in metastatic breast cancer patients treated with weekly trastuzumab and paclitaxel: association with HER2 status by immunohistochemistry and fluorescence in situ hybridization and with response rate.
     Ann Oncol, 16(2): 234-9. [Abstract] [Full-text]
147. Synthesis of 17beta-estradiol-linked platinum(II) complexes and their cytocidal activity on estrogen-dependent and -independent breast tumor cells.
     Bioorg Chem, 33(1): 1-15. [Abstract] [Full-text]
148. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.
     Mol Ther, 11(2): 267-74. [Abstract] [Full-text]
149. A comparison of Monte Carlo and Fermi-Eyges-Hogstrom estimates of heart and lung dose from breast electron boost treatment.
     Int J Radiat Oncol Biol Phys, 61(2): 621-8. [Abstract] [Full-text]
150. Radiotherapy for invasive breast cancer in North America and Europe: results of a survey.
     Int J Radiat Oncol Biol Phys, 61(2): 365-73. [Abstract] [Full-text]
151. Axillary lymph node dose with tangential breast irradiation.
     Int J Radiat Oncol Biol Phys, 61(2): 358-64. [Abstract] [Full-text]
152. Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer.
     Int J Radiat Oncol Biol Phys, 61(2): 348-57. [Abstract] [Full-text]
153. Oligogenic combinations associated with breast cancer risk in women under 53 years of age.
     Hum Genet, 116(3): 208-21. [Abstract] [Full-text]
154. Occupational magnetic fields and female breast cancer: a case-control study using Swedish population registers and new exposure data.
     Am J Epidemiol, 161(3): 250-9. [Abstract] [Full-text]
155. Detection of primary breast carcinoma with a dedicated, large-field-of-view FDG PET mammography device: initial experience.
     Radiology, 234(2): 527-34. [Abstract] [Full-text]
156. Down-regulation of UCRP and UBE2L6 in BRCA2 knocked-down human breast cells.
     Biochem Biophys Res Commun, 328(1): 43-8. [Abstract] [Full-text]
157. Breast cancer: relationship between menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in long-term survivors.
     J Clin Nurs, 14(2): 204-11. [Abstract] [Full-text]
158. Occupational exposure to metalworking fluids and risk of breast cancer among female autoworkers.
     Am J Ind Med, 47(2): 153-60. [Abstract] [Full-text]
159. The role of liquid-based cytology in the investigation of breast lesions using fine-needle aspiration: a cytohistopathological evaluation.
     J Surg Oncol, 89(2): 75-8. [Abstract] [Full-text]
160. Power Doppler sonography of invasive breast carcinoma: does tumor vascularization contribute to prediction of axillary status?
     Radiology, 234(2): 374-80. [Abstract] [Full-text]
161. Real-time quantitative PCR determination of urokinase-type plasminogen activator receptor (uPAR) expression of isolated micrometastatic cells from bone marrow of breast cancer patients.
     Int J Cancer, 114(2): 291-8. [Abstract] [Full-text]
162. Expression and prognostic value of lactoferrin mRNA isoforms in human breast cancer.
     Int J Cancer, 114(2): 299-306. [Abstract] [Full-text]
163. Postmenopausal levels of sex hormones and risk of breast carcinoma in situ: results of a prospective study.
     Int J Cancer, 114(2): 323-7. [Abstract] [Full-text]
164. Active and passive smoking and breast cancer risk in middle-aged Japanese women.
     Int J Cancer, 114(2): 317-22. [Abstract] [Full-text]
165. Comparison of genomic abnormalities between BRCAX and sporadic breast cancers studied by comparative genomic hybridization.
     Int J Cancer, 114(2): 230-6. [Abstract] [Full-text]
166. Ligand- and cell-specific effects of signal transduction pathway inhibitors on progestin-induced vascular endothelial growth factor levels in human breast cancer cells.
     Mol Endocrinol, 19(2): 312-26. [Abstract] [Full-text]
167. Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: results at 4 years.
     Int J Cancer, 114(1): 94-100. [Abstract] [Full-text]
168. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: I. "Loss of function" alterations in the c/EBPdelta growth inhibitory pathway in breast cancer cell lines.
     J Cell Biochem, 93(4): 830-43. [Abstract] [Full-text]
169. Follow-up strategies for women treated for early breast cancer.
     Cochrane Database Syst Rev. [Abstract] [Full-text]
170. Young age: an independent risk factor for disease-free survival in women with operable breast cancer.
     BMC Cancer, 4(1): 82. [Abstract] [Full-text]
171. Tumour size and vascular invasion predict distant metastasis in stage I breast cancer. Grade distinguishes early and late metastasis.
     J Clin Pathol, 58(2): 196-201. [Abstract] [Full-text]
172. Stromal CD10 expression in mammary fibroadenomas and phyllodes tumours.
     J Clin Pathol, 58(2): 185-9. [Abstract] [Full-text]
173. Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer.
     J Clin Pathol, 58(2): 172-7. [Abstract] [Full-text]
174. Acculturation and cancer screening among Latinas: results from the National Health Interview Survey.
     Ann Behav Med, 29(1): 22-8. [Abstract] [Full-text]
175. Intraoperative frozen section examination of axillary sentinel lymph nodes in breast cancer.
     APMIS, 113(1): 7-12. [Abstract] [Full-text]
176. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study.
     BMJ, 330(7485): 220. [Abstract] [Full-text]
177. 30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study.
     BMJ, 330(7485): 217. [Abstract] [Full-text]
178. A novel CYR61-triggered 'CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway.
     Oncogene, 24(5): 761-79. [Abstract] [Full-text]
179. A network of clinically and functionally relevant genes is involved in the reversion of the tumorigenic phenotype of MDA-MB-231 breast cancer cells after transfer of human chromosome 8.
     Oncogene, 24(5): 869-79. [Abstract] [Full-text]
180. Regulation of cyclin expression and cell cycle progression in breast epithelial cells by the helix-loop-helix protein Id1.
     Oncogene, 24(3): 381-9. [Abstract] [Full-text]
181. Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer.
     J Clin Oncol, 23(4): 792-9. [Abstract] [Full-text]
182. Breast cancer treatment guidelines in older women.
     J Clin Oncol, 23(4): 783-91. [Abstract] [Full-text]
183. Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors.
     J Clin Oncol, 23(4): 774-82. [Abstract] [Full-text]
184. Discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy.
     J Clin Oncol, 23(4): 766-73. [Abstract] [Full-text]
185. Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling.
     J Clin Oncol, 23(4): 732-40. [Abstract] [Full-text]
186. Gamma knife radiosurgery for cavernous sinus plasmacytoma in a patient with breast cancer history.
     Surg Neurol, 63(2): 174-6; discussion 176-7. [Abstract] [Full-text]
187. A statistical method to detect chromosomal regions with DNA copy number alterations using SNP-array-based CGH data.
     Comput Biol Chem, 29(1): 47-54. [Abstract] [Full-text]

© 2004-2008 Breast Cancer Research Today. All Rights Reserved.